US Public Status & Risk Snapshot — Sample Review

Who this is for

Importers, distributors, resellers, buyers, and supplier qualification teams reviewing one US medical device line before onboarding, distributing, buying, tendering, or responding to customer or supplier questions.

• · Does the manufacturer or US-side party hold an active FDA Establishment Registration with a device listing entry that matches the product searched?
• · Under what public premarket pathway is the device legally marketed in the US? 510(k), PMA, De Novo, or a 510(k)-exempt classification?
• · What is the likely FDA product code and 21 CFR regulation citation?
• · Are there public FDA recalls, warning letters, enforcement actions, or MAUDE adverse-event records touching the manufacturer or product family in the past 24-36 months?
• · Where are the missing or uncertain fields in public records that the buyer should clarify with the supplier?

Source basis

• FDA import review. At the import or offered-for-import stage, FDA reviews applicable medical device requirements, including registration / listing and applicable premarket evidence (Importing Medical Devices).
• Registration / listing is not approval. Registration and listing tells FDA where medical devices are made and what is being made; it is not approval, clearance, certification, or authorization (Important reminders).
• Premarket evidence (where applicable). 510(k) clearance, De Novo authorization, and PMA approval are published by FDA as separate fields and are reported as such in the Snapshot.
• Recalls, warning letters, import alerts. Sourced from FDA’s Recalls, Corrections and Removals, Warning Letters, and Import Alerts indexes.
• Boundary. A Status Snapshot is a source-backed public-record check — not a compliance certificate, legal advice, an import authorization, or a purchasing recommendation. Final decisions remain with your qualified RA/QA, regulatory, legal, supplier-quality, and procurement professionals. This US sample is illustrative and uses placeholder identifiers; it is not a real-record report.

• · Cover page with report ID, jurisdiction (United States), product searched, company searched, searched-on date.
• · Per-source as-of date table.
• · FDA Establishment Registration & Device Listing check — FEI, establishment role, listed product code, listed proprietary name.
• · Premarket pathway references — 510(k) K-number, PMA, De Novo, or 510(k)-exempt rationale, with classification regulation citation.
• · FDA recalls / enforcement reports over a 36-month window with classification (I / II / III).
• · FDA warning letters for the manufacturer.
• · MAUDE adverse event sweep over a 24-month window.
• · Missing or uncertain section spelling out gaps in public records.
• · Supplier follow-up questions the buyer can copy-paste into an email.
• · Source appendix with every URL, search keys used, and date searched.

Illustrative only. Specific identifiers shown as [######] are placeholders. In a paid order each identifier resolves to a verified public record.

Executive snapshot — example rows

• · FDA registration and listing do not denote approval, clearance, or authorization of the device by FDA. Registration and listing are administrative obligations on the establishment.
• · 510(k) clearance is a finding of substantial equivalence to a legally marketed predicate device. It is not “FDA approval.” PMA is the FDA approval pathway; 510(k) and De Novo are clearance / authorization pathways.
• · No public signal found does not mean no risk. It means no public record surfaced under the search keys used on the searched-on date.
• · MAUDE is subject to substantial under-reporting and reporting bias. Event counts are public-data signals, not absolute incidence rates.

• · Not legal advice.
• · Not a final regulatory classification.
• · Not a final marketability determination.
• · Not a safety guarantee.
• · Not a substitute for a qualified RA / QA / legal professional.
• · Not a substitute for a Quality Management System, Post-Market Surveillance system, or eQMS software.
• · Not a determination that “no public signal found” means no risk.